$121.73
0.45% yesterday
NYSE, May 20, 10:10 pm CET
ISIN
US29261A1007
Symbol
EHC

Encompass Health Corporation Target price 2025 - Analyst rating & recommendation

Encompass Health Corporation Classifications & Recommendation:

Buy
92%
Hold
8%

Encompass Health Corporation Price Target

Target Price $130.09
Price $121.73
Potential
Number of Estimates 11
11 Analysts have issued a price target Encompass Health Corporation 2026 . The average Encompass Health Corporation target price is $130.09. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 12 Analysts recommend Encompass Health Corporation to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Encompass Health Corporation stock has an average upside potential 2026 of . Most analysts recommend the Encompass Health Corporation stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 5.37 5.89
11.91% 9.59%
EBITDA Margin 21.66% 20.51%
3.43% 5.33%
Net Margin 8.30% 9.14%
14.74% 9.13%

11 Analysts have issued a sales forecast Encompass Health Corporation 2025 . The average Encompass Health Corporation sales estimate is

$5.9b
Unlock
. This is
6.82% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$5.9b 7.41%
Unlock
, the lowest is
$5.9b 6.32%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $5.4b 11.91%
2025
$5.9b 9.59%
Unlock
2026
$6.4b 8.56%
Unlock
2027
$6.9b 7.26%
Unlock
2028
$7.3b 6.55%
Unlock

11 Analysts have issued an Encompass Health Corporation EBITDA forecast 2025. The average Encompass Health Corporation EBITDA estimate is

$1.2b
Unlock
. This is
2.01% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$1.2b 0.97%
Unlock
, the lowest is
$1.2b 3.04%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $1.2b 15.75%
2025
$1.2b 3.75%
Unlock
2026
$1.3b 8.46%
Unlock
2027
$1.4b 7.29%
Unlock
2028
$1.5b 3.47%
Unlock
2029
$1.4b 0.31%
Unlock

EBITDA Margin

2024 21.66% 3.43%
2025
20.51% 5.33%
Unlock
2026
20.49% 0.10%
Unlock
2027
20.50% 0.05%
Unlock
2028
19.91% 2.88%
Unlock

6 Encompass Health Corporation Analysts have issued a net profit forecast 2025. The average Encompass Health Corporation net profit estimate is

$538m
Unlock
. This is
10.20% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$689m 41.28%
Unlock
, the lowest is
$485m 0.43%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $446m 28.41%
2025
$538m 19.59%
Unlock
2026
$596m 10.83%
Unlock
2027
$687m 15.21%
Unlock
2028
$600m 12.63%
Unlock

Net Margin

2024 8.30% 14.74%
2025
9.14% 9.13%
Unlock
2026
9.33% 2.08%
Unlock
2027
10.02% 7.40%
Unlock
2028
8.22% 17.96%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 4.43 5.33
28.41% 19.51%
P/E 22.82
EV/Sales 2.65

6 Analysts have issued a Encompass Health Corporation forecast for earnings per share. The average Encompass Health Corporation EPS is

$5.33
Unlock
. This is
10.12% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$6.83 41.12%
Unlock
, the lowest is
$4.81 0.62%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $4.43 28.41%
2025
$5.33 19.51%
Unlock
2026
$5.91 10.88%
Unlock
2027
$6.81 15.23%
Unlock
2028
$5.95 12.63%
Unlock

P/E ratio

Current 25.13 9.07%
2025
22.82 9.19%
Unlock
2026
20.59 9.77%
Unlock
2027
17.87 13.21%
Unlock
2028
20.46 14.49%
Unlock

Based on analysts' sales estimates for 2025, the Encompass Health Corporation stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.83 17.92%
2025
2.65 6.49%
Unlock
2026
2.44 7.88%
Unlock
2027
2.27 6.76%
Unlock
2028
2.13 6.15%
Unlock

P/S ratio

Current 2.23 28.24%
2025
2.08 6.39%
Unlock
2026
1.92 7.88%
Unlock
2027
1.79 6.76%
Unlock
2028
1.68 6.15%
Unlock

Current Encompass Health Corporation Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
UBS
Locked
Locked
Locked Apr 28 2025
RBC Capital
Locked
Locked
Locked Apr 28 2025
Truist Securities
Locked
Locked
Locked Apr 28 2025
Barclays
Locked
Locked
Locked Apr 25 2025
Keybanc
Locked
Locked
Locked Apr 25 2025
RBC Capital
Locked
Locked
Locked Feb 11 2025
Keybanc
Locked
Locked
Locked Feb 10 2025
Analyst Rating Date
Locked
UBS:
Locked
Locked
Apr 28 2025
Locked
RBC Capital:
Locked
Locked
Apr 28 2025
Locked
Truist Securities:
Locked
Locked
Apr 28 2025
Locked
Barclays:
Locked
Locked
Apr 25 2025
Locked
Keybanc:
Locked
Locked
Apr 25 2025
Locked
RBC Capital:
Locked
Locked
Feb 11 2025
Locked
Keybanc:
Locked
Locked
Feb 10 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today